Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiovascular Diseases | 8 | 2019 | 1017 | 2.040 |
Why?
|
| Atherosclerosis | 7 | 2017 | 698 | 1.970 |
Why?
|
| Obesity | 8 | 2021 | 1063 | 1.390 |
Why?
|
| Body Mass Index | 7 | 2021 | 865 | 1.230 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2021 | 871 | 1.120 |
Why?
|
| Adipose Tissue | 2 | 2017 | 327 | 0.940 |
Why?
|
| Adiposity | 4 | 2021 | 191 | 0.910 |
Why?
|
| Ethnic Groups | 4 | 2017 | 440 | 0.850 |
Why?
|
| Longitudinal Studies | 7 | 2021 | 721 | 0.760 |
Why?
|
| Asian Americans | 2 | 2017 | 98 | 0.750 |
Why?
|
| Body Composition | 3 | 2016 | 365 | 0.740 |
Why?
|
| Middle Aged | 20 | 2021 | 10834 | 0.730 |
Why?
|
| Anthropometry | 2 | 2016 | 82 | 0.710 |
Why?
|
| Sex Factors | 3 | 2016 | 631 | 0.700 |
Why?
|
| Aged | 15 | 2019 | 9492 | 0.690 |
Why?
|
| Obesity, Abdominal | 1 | 2018 | 23 | 0.660 |
Why?
|
| Maternal Exposure | 2 | 2009 | 10 | 0.660 |
Why?
|
| Risk Factors | 13 | 2021 | 3537 | 0.640 |
Why?
|
| Choristoma | 1 | 2017 | 17 | 0.630 |
Why?
|
| Body Fat Distribution | 1 | 2017 | 34 | 0.620 |
Why?
|
| Female | 22 | 2021 | 18173 | 0.620 |
Why?
|
| Blood Glucose | 3 | 2019 | 466 | 0.620 |
Why?
|
| Coronary Disease | 2 | 2015 | 200 | 0.580 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2016 | 110 | 0.570 |
Why?
|
| Male | 20 | 2021 | 17815 | 0.570 |
Why?
|
| Alcohol Drinking | 3 | 2013 | 244 | 0.560 |
Why?
|
| Lactic Acid | 2 | 2013 | 52 | 0.560 |
Why?
|
| Smoking | 3 | 2013 | 427 | 0.540 |
Why?
|
| Humans | 24 | 2021 | 29123 | 0.520 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2015 | 28 | 0.510 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 360 | 0.490 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 863 | 0.450 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 80 | 0.450 |
Why?
|
| Metformin | 1 | 2012 | 19 | 0.450 |
Why?
|
| Cohort Studies | 5 | 2017 | 1688 | 0.450 |
Why?
|
| United States | 9 | 2021 | 3632 | 0.440 |
Why?
|
| Thiazolidinediones | 1 | 2012 | 47 | 0.440 |
Why?
|
| Aged, 80 and over | 7 | 2019 | 3719 | 0.430 |
Why?
|
| Coffee | 2 | 2009 | 10 | 0.430 |
Why?
|
| Diabetes Complications | 1 | 2012 | 171 | 0.410 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 176 | 0.400 |
Why?
|
| Intra-Abdominal Fat | 2 | 2021 | 61 | 0.360 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2010 | 59 | 0.360 |
Why?
|
| Incidence | 6 | 2019 | 1119 | 0.360 |
Why?
|
| Pre-Eclampsia | 1 | 2010 | 53 | 0.360 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 2109 | 0.350 |
Why?
|
| Testicular Neoplasms | 1 | 2009 | 17 | 0.350 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 1379 | 0.340 |
Why?
|
| Cryptorchidism | 1 | 2007 | 4 | 0.320 |
Why?
|
| Caffeine | 1 | 2007 | 31 | 0.310 |
Why?
|
| Heart Failure | 3 | 2021 | 571 | 0.310 |
Why?
|
| Pregnancy | 4 | 2013 | 815 | 0.300 |
Why?
|
| Prevalence | 4 | 2017 | 898 | 0.280 |
Why?
|
| Cross-Sectional Studies | 5 | 2019 | 1362 | 0.280 |
Why?
|
| Adult | 7 | 2019 | 8426 | 0.260 |
Why?
|
| Electrocardiography | 2 | 2019 | 568 | 0.250 |
Why?
|
| Prospective Studies | 4 | 2019 | 2021 | 0.250 |
Why?
|
| Survival Rate | 4 | 2021 | 795 | 0.250 |
Why?
|
| Risk Assessment | 2 | 2021 | 1306 | 0.220 |
Why?
|
| California | 2 | 2013 | 60 | 0.210 |
Why?
|
| African Americans | 3 | 2019 | 1373 | 0.210 |
Why?
|
| Prediabetic State | 1 | 2019 | 54 | 0.170 |
Why?
|
| Aldosterone | 1 | 2019 | 28 | 0.170 |
Why?
|
| Time Factors | 2 | 2016 | 2001 | 0.160 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 83 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2019 | 180 | 0.160 |
Why?
|
| Heart Diseases | 1 | 2019 | 99 | 0.160 |
Why?
|
| Stroke | 2 | 2013 | 548 | 0.160 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 136 | 0.160 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 17 | 0.150 |
Why?
|
| Asia | 1 | 2016 | 17 | 0.150 |
Why?
|
| Infant, Newborn | 2 | 2010 | 599 | 0.150 |
Why?
|
| Hypoglycemia | 1 | 2017 | 41 | 0.150 |
Why?
|
| Fasting | 1 | 2017 | 93 | 0.140 |
Why?
|
| Survival Analysis | 1 | 2017 | 440 | 0.140 |
Why?
|
| Diabetes Mellitus | 2 | 2017 | 368 | 0.140 |
Why?
|
| Mortality | 1 | 2017 | 109 | 0.140 |
Why?
|
| Waist-Hip Ratio | 1 | 2015 | 33 | 0.140 |
Why?
|
| Spices | 1 | 2015 | 2 | 0.140 |
Why?
|
| Models, Statistical | 1 | 2016 | 163 | 0.130 |
Why?
|
| Waist Circumference | 1 | 2015 | 89 | 0.130 |
Why?
|
| Sodium, Dietary | 1 | 2015 | 24 | 0.130 |
Why?
|
| Body Weight | 1 | 2017 | 290 | 0.130 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 709 | 0.130 |
Why?
|
| Postmenopause | 1 | 2017 | 397 | 0.130 |
Why?
|
| Fatty Liver | 1 | 2015 | 66 | 0.120 |
Why?
|
| Feeding Behavior | 1 | 2015 | 159 | 0.120 |
Why?
|
| Albuminuria | 1 | 2015 | 177 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2015 | 167 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2015 | 208 | 0.120 |
Why?
|
| Hispanic Americans | 1 | 2017 | 904 | 0.100 |
Why?
|
| Insulin | 1 | 2012 | 346 | 0.100 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2009 | 11 | 0.090 |
Why?
|
| Young Adult | 2 | 2019 | 2402 | 0.080 |
Why?
|
| Testosterone | 1 | 2009 | 47 | 0.080 |
Why?
|
| Mass Screening | 1 | 2010 | 223 | 0.080 |
Why?
|
| Risk | 1 | 2009 | 289 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2007 | 454 | 0.070 |
Why?
|
| Logistic Models | 1 | 2007 | 727 | 0.070 |
Why?
|
| Ethanol | 1 | 2007 | 185 | 0.070 |
Why?
|
| Risk Management | 1 | 2021 | 29 | 0.050 |
Why?
|
| Pericardium | 1 | 2021 | 50 | 0.050 |
Why?
|
| Mississippi | 1 | 2019 | 24 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 447 | 0.040 |
Why?
|
| Disease Progression | 1 | 2019 | 572 | 0.040 |
Why?
|
| Prognosis | 1 | 2019 | 1362 | 0.030 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2015 | 20 | 0.030 |
Why?
|
| Baltimore | 1 | 2015 | 49 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2015 | 54 | 0.030 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2015 | 4 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 629 | 0.030 |
Why?
|
| Energy Intake | 1 | 2015 | 120 | 0.030 |
Why?
|
| Creatinine | 1 | 2015 | 174 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 426 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 532 | 0.030 |
Why?
|
| Health Behavior | 1 | 2015 | 214 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 3112 | 0.030 |
Why?
|
| Community-Based Participatory Research | 1 | 2013 | 105 | 0.030 |
Why?
|
| Comorbidity | 1 | 2013 | 540 | 0.030 |
Why?
|
Mongraw-Chaffin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(119)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(54)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_